Femasys (FEMY) Receivables (2020 - 2026)
Femasys' (FEMY) quarterly Receivables came in at $151049.0 in Q2 2026, down 40.67% on a YoY basis from $254584.0 in Q2 2025, and down 12.32% quarter-over-quarter from $172264.0 in Q1 2026.
Analysis
Femasys (FEMY) Receivables (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Receivables for 7 consecutive years, with $151049.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables fell 40.67% year-over-year to $151049.0; the trailing twelve-month figure through Jun 2026 stood at $151049.0 (down 40.67% YoY), and the FY2025 full-year result was $616600.0, up 26.26% from the prior year.
- Receivables eased to $151049.0 in Q2 2026 per FEMY's latest filing, from $172264.0 in the prior quarter.
- Across five years, Receivables topped out at $616600.0 in Q4 2025 and bottomed at $77470.0 in Q4 2022.
- Historically, Receivables has averaged $228169.2 across 5 years, with a median of $163024.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Receivables sank 43.45% in 2023, then soared 393.77% in 2024.
- Over 5 years, Receivables stood at $77470.0 in 2022, then climbed by 27.67% to $98906.0 in 2023, then jumped by 393.77% to $488373.0 in 2024, then grew by 26.26% to $616600.0 in 2025, then slumped by 75.5% to $151049.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $151049.0, $172264.0, and $616600.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.67 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 6.36 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 3.74 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 3.18 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 955.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 2.08 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 1.28 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 151,049.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151,049.00 |
| Mar 31, 2026 | 172,264.00 |
| Dec 31, 2025 | 616,600.00 |
| Sep 30, 2025 | 572,199.00 |
| Jun 30, 2025 | 254,584.00 |
| Mar 31, 2025 | 233,598.00 |
| Dec 31, 2024 | 488,373.00 |
| Sep 30, 2024 | 378,290.00 |
| Jun 30, 2024 | 92,535.00 |
| Mar 31, 2024 | 120,529.00 |
| Dec 31, 2023 | 98,906.00 |
| Sep 30, 2023 | 103,556.00 |
| Jun 30, 2023 | 155,746.00 |
| Mar 31, 2023 | 123,955.00 |
| Dec 31, 2022 | 77,470.00 |
| Sep 30, 2022 | 183,130.00 |
| Jun 30, 2022 | 113,960.00 |
| Mar 31, 2022 | 170,302.00 |
| Dec 31, 2021 | 84,258.00 |
| Sep 30, 2021 | 143,459.00 |